{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG|Designated/Approved|Treatment of dystrophic epidermolysis bullosa" in comments (approximate match)
Showing 1 - 1 of 1 results
Status:
Possibly Marketed Outside US
Source:
BLA125774
(2023)
Source URL:
First approved in 2023
Source:
BLA125774
Source URL:
Class:
STRUCTURALLY DIVERSE